GLAUCOMA MEDS

EyeWorld Magazine: August�2006

This article explains what we all probably already know. 40% of patients on a prostaglandin analogue will need adjunctive therapy, and that a topical carbonic anhydrase inhibitor is more effective than an alpha-agonist (brimonodine or Alphagan-P) as an adjunct. Also brimonodine's effect wears off over time and does not display as flat a diurnal curve as Azopt (or Trusopt).

Comments

  1. Kevin,
    Ironically, the Allergan rep. just showed me a report yesterday concluding that Alphagan-P is the best adjunctive therapy for glaucoma. I forget which source it was from.
    Sometimes it's hard to know which way to go when there are conflicting studies!

    ReplyDelete

Post a Comment

Leave a Comment or Question:

Popular posts from this blog

IMPLANTABLE COLLAMER LENS APPEARS BETTER THAN LASIK OR PRK FOR MODERATE TO HIGH MYOPIC PATIENTS

RINSING YOUR CONTACT LENS CASE IS NOT ENOUGH